The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA and more. There is no shortage ...

The Department of Justice has filed a complaint against Aetna, Elevance Health, Humana, eHealth, GoHealth, and SelectQuote, ...

Businesses are struggling with the high cost of healthcare benefits for their employees. As companies prioritize their employees’ well-being, healthcare benefits are often their largest expense ...

Uncertainty dominates the healthcare spectrum, with the HHS led by the most anti-establishment head in modern times, Robert Kennedy Jr. It is sparking a lot of conversation about what the impact ...

After consistently experiencing double-digit annual increases in healthcare costs with traditional health insurance, pest control company Rollins knew it had to do things differently for its ...

German medical device company seca rolled out the first portable body composition scanner designed for primary care settings on Thursday. The product, called Alpha, seeks to give primary care ...

Over a million lives have been lost to drug overdoses since the start of the overdose crisis, with opioids accounting for 72% of these deaths. In 2023, the FDA approved naloxone (brand name Narcan ...

A new report highlights email as an Achilles’ Heel in healthcare cybersecurity. The Paubox report surveyed 150 healthcare IT leaders and found 63% reported data breaches or security incidents ...

This week, two bipartisan members of the Senate Budget Committee launched an investigation into private equity and its impact on healthcare. They initiated the probe to get answers about ...

Blue Cross Blue Shield of Massachusetts recently entered into a partnership with American Well on a new telemedicine pilot that will permit direct engagement for consumers with their health ...

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment ...

Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal to acquire Regulus Therapeutics, a biotech with a drug ready for pivotal testing in a ...